The study of Dexmedetomidine with Ropivacaine in Eye Block for retina surgeries
Phase 4
- Conditions
- Health Condition 1: H330- Retinal detachment with retinal break
- Registration Number
- CTRI/2024/08/072433
- Lead Sponsor
- ethradhama Super Speciality Eye Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA 1,2,3
Satisfactory akinesia following subtenon blocks and predictable surgical time of less than 3hours
Exclusion Criteria
Known allergy to dexmedetomidines
Patients with a single eye
History of sleep apnea
Severe Cardiac, respiratory and renal disease
Drowsy on the day of surgery with Ramsay Level of Sedation Scale Score more than 3
Normal sinus bradycardia in ECG, Baseline Hypotension recorded
Dementia
Communication disabilities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect of the adjuvant added in sub-tenons block on motor and sensory block.Timepoint: 3months
- Secondary Outcome Measures
Name Time Method Adverse effect associated with 20mcg Dexmedetomidine as adjuvant in subtenon blockTimepoint: 3 months